Boehringer Ingelheim’s Jascayd has received European marketing authorisation for idiopathic [...]

The EMA’s CHMP has recommended EU approval of Lynavoy for [...]

The EMA’s CHMP has recommended approval of NEZGLYAL for boys [...]

The European Commission has approved Erbitux (cetuximab) in combination with [...]

Otsuka Pharmaceutical Europe has received an amended European Commission marketing [...]

The European Commission has granted orphan drug designation to Chiesi [...]

The European Commission has approved BRAFTOVI in combination with cetuximab [...]

Munich-based Ethris GmbH is part of a seven-organisation European consortium [...]